Gilead Sciences Inc
Drug Manufacturers - General
Healthcare
GILD
1.26 B shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
111.88
52 week high
120.47
high
115.57
52 week low
0.00
low
111.75
growth
37.43 %
previous Close
112.49
P/E ratio
57
market cap
137 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
2.01 %
11.05 %
eps surprise
2.55 %
net profit margin
0.00 %
-19.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top